Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil/Propofol vs Fentanyl/Midazolam for Sedation in Therapeutic Hypothermia
NCT00667043Phase 4Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2008
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil and propofol injection (veterinary) in cardiac arrest (SCA) (2 arms), sponsored by Norwegian University of Science and Technology. Primary endpoint: Time from termination of sedation to extubation. Started Apr 2008; status: completed.
02
Drugs
remifentanilpropofol injection (veterinary)
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT00667043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667043.